Top Stocks
Top Analyst Stocks
Top Smart Score Stocks
Top Insiders Stocks
Popular
Stock Screener
Top Online Growth Stocks
Trending Stocks
Penny Stock Screener
Dividend Investing
Dividend Calculator
Dividend Yield Calculator
Dividend Stocks
Dividend News
Dividend Calendar
ETFs
ETF Center
SPY ETF
QQQ ETF
Stock Comparison
ChatGPT Stocks
Value Stocks
Airline Stocks
AI Stocks
Oil Stocks
Bank Stocks
FAANG Stocks
Compare More Stocks…
Calendars
IPO Calendar
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
Market Holidays
Daily Analyst Ratings
Daily Insider Trading
Research Tools
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
News
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
My Watchlist
Smart Portfolio
About Us
About TipRanks
Contact Us
Working with TipRanks
Enterprise Solutions
Tools for Trading Platforms
Data for Hedge Funds
Best Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Smart Portfolio
Expert Center
Ideas
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Top Stocks
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
Top Experts
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Research Tools
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Comparisons
Stock Comparison
POPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
Smart Portfolio
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Calendars
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
News
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About Us
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing
AVXL
Stock Latest News
The Fly
Anavex appoints Kun Jin as VP, head of biostatistics
11d ago
AVXL
The Fly
Anavex price target lowered to $28 from $35 at BTIG
1M ago
AVXL
The Fly
Anavex reports Q1 EPS (17c), consensus (19c)
1M ago
AVXL
Press Releases
Anavex Life Sciences Reports Fiscal 2023 First Quarter Financial Results
1M ago
AVXL
The Fly
Anavex could submit blarcamesine to FDA by year end, says H.C. Wainwright
1M ago
AVXL
The Fly
Anavex announces exceeding enrollment target for ANAVEX2-73 EXCELLENCE trial
2M ago
AVXL
Press Releases
Anavex Life Sciences Announces Exceeding of Enrollment Target for the ANAVEX®2-73 (blarcamesine) EXCELLENCE Phase 2/3 Rett Syndrome Clinical Trial
2M ago
AVXL
The Fly
Anavex price target raised to $50 from $42 at H.C. Wainwright
3M ago
AVXL
The Fly
Anavex appoints Grimmer to Scientific Advisory Board
3M ago
AVXL
Press Releases
Anavex Strengthens Scientific Advisory Board with Investigator from Phase 2b/3 Alzheimer’s Trial
3M ago
AVXL
Press Releases
Anavex Life Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
3M ago
AVXL
The Fly
Unusually active option classes on open December 6th
3M ago
CDE
CGC
The Fly
Anavex downgraded to Neutral from Overweight at Cantor Fitzgerald
3M ago
AVXL
Press Releases
Anavex Life Sciences to Announce Management Webcast and Conference Call on Monday December 5, 2022
4M ago
AVXL
Market News
Anavex Shoots Up After Positive Topline Data
4M ago
AVXL
The Fly
Anavex price target raised to $80 from $40 at JonesTrading
4M ago
AVXL
BIIB
Press Releases
ANAVEX®2–73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoints, Showing Statistically Significant Reduction of Clinical Decline in Global Clinical Study of Patients With Early Alzheimer’s Disease
4M ago
AVXL
The Fly
Anavex phase 2B/3 study of blarcamesine met primary and key secondary endpoints
4M ago
AVXL
Stock Analysis & Ideas
Anavex Stock: Volatility Beckons but the Pipeline Has Big Potential, Says Analyst
4M ago
AVXL
The Fly
Anavex reports Q4 EPS (18c), consensus (16c)
4M ago
AVXL
Press Releases
Anavex Life Sciences to Announce Fiscal 2022 Year End Financial Results on Monday November 28, 2022
4M ago
AVXL
The Fly
Anavex management to meet with Piper Sandler
4M ago
AVXL
Press Releases
Anavex Life Sciences Announces Late-Breaking Presentation of Phase 2b/3 Data of Oral ANAVEX®2-73 (blarcamesine) for Early Alzheimer’s Disease at the Upcoming Clinical Trials on Alzheimer’s Disease (CTAD) Congress 2022
5M ago
AVXL
Press Releases
Anavex Life Sciences Announces Issuance of U.S. Patent Covering ANAVEX®2-73 (blarcamesine) for Neurodevelopmental Disorders Therapy
6M ago
AVXL
Press Releases
Anavex Life Sciences Reports New Publication in Medical Journal Highlighting the Relevance of SIGMAR1 Activation to Compensate for Early Alzheimer’s Disease
7M ago
AVXL
Press Releases
Anavex Life Sciences Provides Business Update and Reports Fiscal 2022 Third Quarter Financial Results
7M ago
AVXL
Press Releases
Anavex Announces First Entire Clinical Alzheimer’s Gene Pathway Data of ANAVEX®2-73 at AAIC 2022
8M ago
AVXL
Market News
Anavex Life Sciences Updates 2 Key Risk Factors
1y ago
AVXL
Stock Analysis & Ideas
3 “Strong Buy” Stocks With Robust Upside Ahead
2y ago
AVXL
IMBI
Show More
You need to enable JavaScript to run this app.